| Institution: | 1. Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada;2. Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada;3. MRC Integrative Epidemiology Unit (IEU) and School of Social and Community Medicine, University of Bristol, Bristol, UK;4. Data Science Institute and Lancaster University Medical School, Lancaster, UK;5. Department of Preventive Medicine and Public Health, University of Kansas School of Medicine, Kansas City, KS, USA;6. Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, RI, USA;7. Departments of Medicine and Bioengineering and Therapeutic Sciences, Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco, CA, USA;8. Department of Psychiatry, Perelman School of Medicine, and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA;9. Department of Psychology, University at Buffalo, SUNY, Buffalo, NY, USA;10. Department of Behavioral Science, University of Texas, MD Anderson Cancer Center, Houston, TX, USA;11. Division of Schizophrenia, Centre for Addiction and Mental Health, Toronto, ON, Canada;12. Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, ON, Canada;13. Department of Psychiatry, Annenberg School for Communication, and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA;14. Department of Psychiatry, University of Toronto, Toronto, ON, Canada |
